Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ)
300391.SZ Stock Price Chart
Explore Changjiang Pharmaceutical Group Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300391.SZ price movements and trends.
300391.SZ Company Profile
Discover essential business fundamentals and corporate details for Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1 Aug 2014
Employees
352.00
Website
https://www.chinakangyue.comCEO
Luhong Ning
Description
Changjiang Pharmaceutical Group Co., Ltd., together with its subsidiaries, designs, researches, develops, produces, and sells turbochargers in China. It offers turbocharger housing, engine exhaust manifolds, and valve body auto parts, as well as engines. The company also produces and sells solar cell module equipment and photovoltaic modules, as well as engages in the solar energy, lithium batteries, energy storage, and other energy industry businesses. Its products are used in automobiles, construction machinery, agricultural machinery, ship power, generator sets, and other industries. Kangyue Technology Co., Ltd. also exports its products to Americas, Europe, East Asia, and internationally. The company was formerly known as Kangyue Technology Co., Ltd. and changed its name to Changjiang Pharmaceutical Group Co., Ltd. in March 2023. Changjiang Pharmaceutical Group Co., Ltd. was founded in 1963 and is based in Shouguang, China.
300391.SZ Financial Timeline
Browse a chronological timeline of Changjiang Pharmaceutical Group Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 21 May 2025
EPS came in at -¥1.28 , while revenue for the quarter reached ¥10.62M .
Earnings released on 31 Mar 2025
EPS came in at -¥0.17 , while revenue for the quarter reached ¥103.68M .
Earnings released on 29 Sept 2024
EPS came in at -¥0.08 , while revenue for the quarter reached ¥27.35M .
Earnings released on 29 Jun 2024
EPS came in at -¥0.30 , while revenue for the quarter reached ¥13.87M .
Earnings released on 21 May 2024
EPS came in at -¥0.14 , while revenue for the quarter reached ¥59.09M .
Earnings released on 28 Feb 2024
EPS came in at -¥1.40 , while revenue for the quarter reached ¥175.69M .
Earnings released on 21 Feb 2024
EPS came in at -¥0.26 , while revenue for the quarter reached ¥545.85M .
Earnings released on 30 Jun 2023
EPS came in at -¥0.00 , while revenue for the quarter reached ¥339.22M .
Earnings released on 31 Mar 2023
EPS came in at -¥0.07 , while revenue for the quarter reached ¥136.79M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.14 , while revenue for the quarter reached ¥192.68M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.19 , while revenue for the quarter reached ¥430.80M .
Earnings released on 30 Jun 2022
EPS came in at -¥0.16 , while revenue for the quarter reached ¥446.45M .
Earnings released on 31 Mar 2022
EPS came in at ¥0.04 , while revenue for the quarter reached ¥545.40M .
Earnings released on 31 Dec 2021
EPS came in at -¥0.14 , while revenue for the quarter reached ¥543.67M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.04 , while revenue for the quarter reached ¥520.64M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.07 , while revenue for the quarter reached ¥512.49M .
Earnings released on 28 Apr 2021
EPS came in at ¥0.07 , while revenue for the quarter reached ¥569.40M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.17 , while revenue for the quarter reached ¥785.15M .
Earnings released on 30 Sept 2020
EPS came in at ¥0.02 , while revenue for the quarter reached ¥276.41M .
300391.SZ Stock Performance
Access detailed 300391.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.